HKPD
Cellyan Biotechnology Co., Ltd
Price Chart
Latest Quote
$0.37
+0.01 (+1.69%)
Current Price
| Previous Close | $0.36 |
| Open | $0.36 |
| Day High | $0.40 |
| Day Low | $0.33 |
| Volume | 52,268 |
Stock Information
| Shares Outstanding | 16.35M |
| Total Debt | $2.27M |
| Cash Equivalents | $2.48M |
| Revenue | $16.36M |
| Net Income | $-702K |
| Sector | Healthcare |
| Industry | Medical Distribution |
| Market Cap | $9.16M |
| EPS (TTM) | $-0.06 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $3.75M |
| Sales | $16.36M |
| Income | $-702K |
| Book/sh | $0.47 |
| Cash/sh | $0.15 |
| Employees | 27 |
Financial Ratios
| Quick Ratio | 2.51 |
| Current Ratio | 2.93 |
| Debt/Eq | 44.19 |
| EPS Growth TTM | -81.40% |
Returns & Margins
| ROA | -3.94% |
| ROE | -13.38% |
| Gross Margin | 8.80% |
| Operating Margin | 2.96% |
| Profit Margin | -4.29% |
Ownership
| Insider Ownership | 31.31% |
| Institutional Ownership | 0.32% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 0.56 |
| P/B | 0.83 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.46 |
| SMA50 | $0.56 |
| SMA200 | $0.85 |
| RSI | 37.96 |
| ATR | 0.0698 |
| Shares Float | 7.36M |
| Short Float | 0.78% |
| Short Ratio | 0.18 |
| Rel Volume | 0.15 |
Performance History
| Week | -15.95% |
| Month | -26.42% |
| Quarter | -40.91% |
| 6 Months | -44.29% |
| YTD | -51.67% |
| Year | -73.47% |
| 10 Years | -86.17% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-24 | $0.39 | 114,182 |
| 2026-06-23 | $0.36 | 95,600 |
| 2026-06-22 | $0.35 | 177,100 |
| 2026-06-18 | $0.40 | 35,000 |
| 2026-06-17 | $0.41 | 126,800 |
| 2026-06-16 | $0.46 | 84,100 |
| 2026-06-15 | $0.44 | 79,400 |
| 2026-06-12 | $0.41 | 66,200 |
| 2026-06-11 | $0.45 | 640,700 |
| 2026-06-10 | $0.45 | 10,386,400 |
| 2026-06-09 | $0.33 | 2,192,100 |
| 2026-06-08 | $0.49 | 1,008,500 |
| 2026-06-05 | $0.50 | 36,000 |
| 2026-06-04 | $0.50 | 10,900 |
| 2026-06-03 | $0.52 | 26,800 |
| 2026-06-02 | $0.52 | 6,700 |
| 2026-06-01 | $0.55 | 43,100 |
| 2026-05-29 | $0.52 | 52,700 |
| 2026-05-28 | $0.52 | 45,900 |
| 2026-05-27 | $0.54 | 19,200 |
| 2026-05-26 | $0.54 | 13,200 |
About Cellyan Biotechnology Co., Ltd
Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services. It also offers custom clearance, drugs enlisting, warehouse, and other logistics services. The company serves e-commerce platform logistics partners, merchants, and pharmaceutical distributors. The company was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and changed its name to Cellyan Biotechnology Co., Ltd in December 2025. Cellyan Biotechnology Co., Ltd was incorporated in 2023 and is based in Yau Tong, Hong Kong.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|
| Revenue | |||
| Reconciled Cost Of Revenue | $17,898,659 | $13,129,699 | $9,817,066 |
| Cost Of Revenue | $17,898,659 | $13,129,699 | $9,817,066 |
| Total Revenue | $20,313,818 | $16,688,364 | $12,555,991 |
| Operating Revenue | $20,313,818 | $16,688,364 | $12,555,991 |
| Expenses | |||
| Interest Expense | $97,667 | $82,766 | $23,242 |
| Total Expenses | $20,113,052 | $15,015,116 | $11,478,917 |
| Other Income Expense | $-68,728 | $-64,987 | $-33,281 |
| Other Non Operating Income Expenses | $-10,516 | $-2,470 | $-2,041 |
| Net Non Operating Interest Income Expense | $-95,926 | $-82,292 | $-23,023 |
| Interest Expense Non Operating | $97,667 | $82,766 | $23,242 |
| Operating Expense | $2,214,393 | $1,885,417 | $1,661,851 |
| Other Operating Expenses | $-1,466 | $-4,038 | $-96,229 |
| Income & Earnings | |||
| Net Income From Continuing Operation Net Minority Interest | $-27,056 | $1,329,717 | $998,196 |
| Net Interest Income | $-95,926 | $-82,292 | $-23,023 |
| Interest Income | $1,741 | $474 | $219 |
| Normalized Income | $21,551 | $1,384,232 | $1,028,749 |
| Net Income From Continuing And Discontinued Operation | $-27,056 | $1,329,717 | $998,196 |
| Total Operating Income As Reported | $132,038 | $1,608,261 | $1,043,793 |
| Net Income Common Stockholders | $-27,056 | $1,329,717 | $998,196 |
| Net Income | $-27,056 | $1,329,717 | $998,196 |
| Net Income Including Noncontrolling Interests | $-27,056 | $1,329,717 | $998,196 |
| Net Income Continuous Operations | $-27,056 | $1,329,717 | $998,196 |
| Pretax Income | $36,112 | $1,525,969 | $1,020,770 |
| Special Income Charges | $-7,526 | $708 | $0 |
| Interest Income Non Operating | $1,741 | $474 | $219 |
| Operating Income | $200,766 | $1,673,248 | $1,077,074 |
| Gross Profit | $2,415,159 | $3,558,665 | $2,738,925 |
| Per Share | |||
| Diluted EPS | $-0.00 | $0.12 | $0.09 |
| Basic EPS | $-0.00 | $0.12 | $0.09 |
| Other | |||
| Tax Effect Of Unusual Items | $-9,605 | $-8,002 | $-687 |
| Tax Rate For Calcs | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $1,265,362 | $2,596,828 | $1,789,838 |
| Total Unusual Items | $-58,212 | $-62,517 | $-31,240 |
| Total Unusual Items Excluding Goodwill | $-58,212 | $-62,517 | $-31,240 |
| Reconciled Depreciation | $1,073,371 | $925,576 | $714,586 |
| EBITDA (Bullshit earnings) | $1,207,150 | $2,534,311 | $1,758,598 |
| EBIT | $133,779 | $1,608,735 | $1,044,012 |
| Diluted Average Shares | $10,205,479 | $11,000,000 | $11,000,000 |
| Basic Average Shares | $10,205,479 | $11,000,000 | $11,000,000 |
| Diluted NI Availto Com Stockholders | $-27,056 | $1,329,717 | $998,196 |
| Tax Provision | $63,168 | $196,252 | $22,574 |
| Gain On Sale Of Ppe | $-7,526 | $-10,851 | $0 |
| Gain On Sale Of Business | $0 | $11,559 | $0 |
| Gain On Sale Of Security | $-50,686 | $-63,225 | $-31,240 |
| Selling General And Administration | $2,215,859 | $1,889,455 | $1,758,080 |
| Minority Interests | - | $0 | $0 |
Fetched: 2026-06-24
Balance Sheet (Annual)
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|
| Assets | |||
| Net Tangible Assets | $4,893,332 | $4,221,834 | $581,213 |
| Total Assets | $9,417,276 | $8,667,228 | $3,406,754 |
| Total Non Current Assets | $690,171 | $865,518 | $658,290 |
| Goodwill And Other Intangible Assets | $96,437 | $31,825 | $4,029 |
| Other Intangible Assets | $96,437 | $31,825 | $4,029 |
| Current Assets | $8,727,105 | $7,801,710 | $2,748,464 |
| Current Deferred Assets | $0 | $1,260,075 | $0 |
| Restricted Cash | $400 | $7,682 | $0 |
| Prepaid Assets | $447,912 | $1,262,351 | $302,555 |
| Inventory | $559,982 | $933,299 | $190,887 |
| Receivables | $4,713,260 | $3,718,728 | $1,730,409 |
| Accounts Receivable | $4,655,951 | $3,698,757 | $1,646,491 |
| Allowance For Doubtful Accounts Receivable | $0 | $0 | $0 |
| Gross Accounts Receivable | $4,655,951 | $3,698,757 | $1,646,491 |
| Cash Cash Equivalents And Short Term Investments | $3,005,551 | $619,575 | $524,613 |
| Cash And Cash Equivalents | $748,721 | $619,575 | $524,613 |
| Cash Financial | $748,721 | $619,575 | $524,613 |
| Other Receivables | - | - | $236,359 |
| Debt | |||
| Net Debt | $1,126,634 | $714,898 | - |
| Total Debt | $2,374,870 | $2,086,813 | $691,076 |
| Long Term Debt And Capital Lease Obligation | $1,510,209 | $1,237,112 | $271,452 |
| Long Term Debt | $1,503,797 | $1,119,276 | $116,862 |
| Current Debt And Capital Lease Obligation | $864,661 | $849,701 | $419,624 |
| Current Debt | $371,558 | $215,197 | $62,353 |
| Other Current Borrowings | $371,558 | $180,493 | $62,353 |
| Liabilities | |||
| Total Liabilities Net Minority Interest | $4,427,507 | $4,413,569 | $2,821,512 |
| Total Non Current Liabilities Net Minority Interest | $1,510,209 | $1,237,112 | $271,452 |
| Current Liabilities | $2,917,298 | $3,176,457 | $2,550,060 |
| Current Deferred Liabilities | $124,507 | $191,066 | $268,028 |
| Payables And Accrued Expenses | $1,928,130 | $2,135,690 | $1,862,408 |
| Payables | $1,903,065 | $2,101,910 | $1,796,612 |
| Other Payable | $68,885 | $59,267 | $82,610 |
| Total Tax Payable | $105,058 | $218,831 | $22,543 |
| Accounts Payable | $1,727,809 | $1,323,135 | $1,400,644 |
| Equity | |||
| Common Stock Equity | $4,989,769 | $4,253,659 | $585,242 |
| Total Equity Gross Minority Interest | $4,989,769 | $4,253,659 | $585,242 |
| Stockholders Equity | $4,989,769 | $4,253,659 | $585,242 |
| Gains Losses Not Affecting Retained Earnings | $10,819 | $-4,858 | $-4,342 |
| Other Equity Adjustments | $10,819 | $-4,858 | $-4,342 |
| Retained Earnings | $1,504,052 | $1,531,108 | $201,391 |
| Other Equity Interest | - | $-300,000 | $-6,843 |
| Other | |||
| Ordinary Shares Number | $11,000,000 | $11,000,000 | $11,000,000 |
| Share Issued | $11,000,000 | $11,000,000 | $11,000,000 |
| Tangible Book Value | $4,893,332 | $4,221,834 | $581,213 |
| Invested Capital | $6,865,124 | $5,588,132 | $764,457 |
| Working Capital | $5,809,807 | $4,625,253 | $198,404 |
| Capital Lease Obligations | $499,515 | $752,340 | $511,861 |
| Total Capitalization | $6,493,566 | $5,372,935 | $702,104 |
| Additional Paid In Capital | $3,463,898 | $3,017,409 | $388,193 |
| Capital Stock | $11,000 | $10,000 | $6,843 |
| Common Stock | $11,000 | $10,000 | $6,843 |
| Long Term Capital Lease Obligation | $6,412 | $117,836 | $154,590 |
| Current Deferred Revenue | $124,507 | $191,066 | $268,028 |
| Current Capital Lease Obligation | $493,103 | $634,504 | $357,271 |
| Line Of Credit | $0 | $34,704 | $0 |
| Current Accrued Expenses | $25,065 | $33,780 | $65,796 |
| Dueto Related Parties Current | $1,313 | $500,677 | $290,815 |
| Net PPE | $593,734 | $833,693 | $654,261 |
| Accumulated Depreciation | $-141,841 | $-87,550 | $-49,207 |
| Gross PPE | $735,575 | $921,243 | $703,468 |
| Leases | $67,424 | $48,493 | $24,739 |
| Other Properties | $650,435 | $855,139 | $599,725 |
| Machinery Furniture Equipment | $17,716 | $17,611 | $79,004 |
| Properties | $0 | $0 | $0 |
| Inventories Adjustments Allowances | $0 | $0 | $0 |
| Finished Goods | $519,145 | $879,422 | $124,932 |
| Raw Materials | $40,837 | $53,877 | $65,955 |
| Duefrom Related Parties Current | $57,309 | $19,971 | $83,918 |
| Other Short Term Investments | $2,256,830 | $0 | - |
Fetched: 2026-06-24
Cash Flow Statement (Annual)
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|
| Free Cash Flow | |||
| Free Cash Flow | $414,226 | $-482,348 | $1,609,374 |
| Operating Activities | |||
| Operating Cash Flow | $569,214 | $-394,330 | $1,727,079 |
| Cash Flow From Continuing Operating Activities | $569,214 | $-394,330 | $1,727,079 |
| Operating Gains Losses | $43,145 | $-708 | - |
| Investing Activities | |||
| Capital Expenditure | $-154,988 | $-88,018 | $-117,705 |
| Investing Cash Flow | $-2,454,963 | $-40,796 | $-132,095 |
| Cash Flow From Continuing Investing Activities | $-2,454,963 | $-40,796 | $-132,095 |
| Net Other Investing Changes | - | $13,993 | $-14,390 |
| Financing Activities | |||
| Issuance Of Capital Stock | $4,300,000 | $509,501 | $0 |
| Financing Cash Flow | $1,995,114 | $537,315 | $-1,155,671 |
| Cash Flow From Continuing Financing Activities | $1,995,114 | $537,315 | $-1,155,671 |
| Net Other Financing Charges | $-1,377,579 | $-345,217 | - |
| Net Common Stock Issuance | $4,300,000 | $509,501 | $0 |
| Common Stock Issuance | $4,300,000 | $509,501 | $0 |
| Other | |||
| Repayment Of Debt | $-2,516,404 | $-1,769,416 | $-1,344,879 |
| Issuance Of Debt | $1,589,097 | $2,142,447 | $189,208 |
| Interest Paid Supplemental Data | $97,667 | $82,766 | $57,327 |
| Income Tax Paid Supplemental Data | $294,831 | $0 | $0 |
| End Cash Position | $749,121 | $627,257 | $524,613 |
| Beginning Cash Position | $627,257 | $524,613 | $84,979 |
| Effect Of Exchange Rate Changes | $12,499 | $455 | $321 |
| Changes In Cash | $109,365 | $102,189 | $439,313 |
| Net Issuance Payments Of Debt | $-927,307 | $373,031 | $-1,155,671 |
| Net Long Term Debt Issuance | $-927,307 | $373,031 | $-1,155,671 |
| Long Term Debt Payments | $-2,516,404 | $-1,769,416 | $-1,344,879 |
| Long Term Debt Issuance | $1,589,097 | $2,142,447 | $189,208 |
| Net Investment Purchase And Sale | $-2,299,975 | $0 | $0 |
| Purchase Of Investment | $-2,299,975 | $0 | $0 |
| Net Intangibles Purchase And Sale | $-85,072 | $-35,282 | $-3,062 |
| Purchase Of Intangibles | $-85,072 | $-35,282 | $-3,062 |
| Net PPE Purchase And Sale | $-69,916 | $-19,507 | $-114,643 |
| Sale Of PPE | $0 | $33,229 | $0 |
| Purchase Of PPE | $-69,916 | $-52,736 | $-114,643 |
| Change In Working Capital | $-520,246 | $-2,648,915 | $14,297 |
| Change In Other Working Capital | $-163,462 | $93,602 | $337,533 |
| Change In Payables And Accrued Expense | $282,009 | $91,032 | $977,844 |
| Change In Payable | $282,009 | $91,032 | $977,844 |
| Change In Account Payable | $396,883 | $-105,220 | $955,270 |
| Change In Tax Payable | $-114,874 | $196,252 | $22,574 |
| Change In Income Tax Payable | $-114,874 | $196,252 | $22,574 |
| Change In Inventory | $378,199 | $-741,950 | $-191,155 |
| Change In Receivables | $-1,016,992 | $-2,091,599 | $-1,109,925 |
| Changes In Account Receivables | $-918,793 | $-2,047,556 | $-929,509 |
| Depreciation Amortization Depletion | $1,073,371 | $925,576 | $714,586 |
| Depreciation And Amortization | $1,073,371 | $925,576 | $714,586 |
| Depreciation | $1,073,371 | $925,576 | $714,586 |
| Gain Loss On Investment Securities | $43,145 | - | - |
| Gain Loss On Sale Of PPE | $0 | $10,851 | $0 |
| Gain Loss On Sale Of Business | $0 | $-11,559 | $0 |
| Net Income From Continuing Operations | $-27,056 | $1,329,717 | $998,196 |
| Change In Prepaid Assets | - | - | $-180,416 |
Fetched: 2026-06-24